After terminating a non binding letter of intent for a potential merger with QumulusAI, Vincerx Pharma will wind down, the company announced April 8. The San Mateo, California–based biotech, whose pipeline focused on addressing unmet medical needs for cancer patients, is also exploring monetization of assets and outlicensing opportunities.
All entries for: Vincerx Pharma
April 10, 2025
Vincerx Pharma
Company Closure
Palo Alto, CA
1-50 employees
Disease Area: Oncology
Drug Type: Biologic, Small Molecule